363 related articles for article (PubMed ID: 29207222)
1. Urea and impairment of the Gut-Kidney axis in Chronic Kidney Disease.
Di Iorio BR; Marzocco S; Nardone L; Sirico M; De Simone E; Di Natale G; Di Micco L
G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207222
[TBL] [Abstract][Full Text] [Related]
2. The gut microbiota and its relationship with chronic kidney disease.
Plata C; Cruz C; Cervantes LG; Ramírez V
Int Urol Nephrol; 2019 Dec; 51(12):2209-2226. PubMed ID: 31576489
[TBL] [Abstract][Full Text] [Related]
3. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease and the gut microbiome.
Hobby GP; Karaduta O; Dusio GF; Singh M; Zybailov BL; Arthur JM
Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1211-F1217. PubMed ID: 30864840
[TBL] [Abstract][Full Text] [Related]
5. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
6. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
[TBL] [Abstract][Full Text] [Related]
7. Microbiota issue in CKD: how promising are gut-targeted approaches?
Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
[TBL] [Abstract][Full Text] [Related]
8. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
Lau WL; Savoj J; Nakata MB; Vaziri ND
Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
[TBL] [Abstract][Full Text] [Related]
9. Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease.
Esgalhado M; Kemp JA; Damasceno NR; Fouque D; Mafra D
Future Microbiol; 2017 Nov; 12():1413-1425. PubMed ID: 29027814
[TBL] [Abstract][Full Text] [Related]
10. Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components.
Ondrussek-Sekac M; Navas-Carrillo D; Orenes-Piñero E
Crit Rev Food Sci Nutr; 2021; 61(9):1490-1502. PubMed ID: 32393049
[TBL] [Abstract][Full Text] [Related]
11. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
Li DY; Tang WHW
Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
[TBL] [Abstract][Full Text] [Related]
13. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
Briskey D; Tucker P; Johnson DW; Coombes JS
Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
[TBL] [Abstract][Full Text] [Related]
14. The gut-kidney axis.
Evenepoel P; Poesen R; Meijers B
Pediatr Nephrol; 2017 Nov; 32(11):2005-2014. PubMed ID: 27848096
[TBL] [Abstract][Full Text] [Related]
15. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota in chronic kidney disease.
Cigarran Guldris S; González Parra E; Cases Amenós A
Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
[TBL] [Abstract][Full Text] [Related]
17. Microbiota and prebiotics modulation of uremic toxin generation.
Koppe L; Fouque D
Panminerva Med; 2017 Jun; 59(2):173-187. PubMed ID: 28001024
[TBL] [Abstract][Full Text] [Related]
18. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
[TBL] [Abstract][Full Text] [Related]
19. Modulation of intestinal microbiota, control of nitrogen products and inflammation by pre/probiotics in chronic kidney disease: a systematic review.
Lopes RCSO; Balbino KP; Jorge MP; Ribeiro AQ; Martino HSD; Alfenas RCG
Nutr Hosp; 2018 Apr; 35(3):722-730. PubMed ID: 29974784
[TBL] [Abstract][Full Text] [Related]
20. The Food-gut Human Axis: The Effects of Diet on Gut Microbiota and Metabolome.
De Angelis M; Garruti G; Minervini F; Bonfrate L; Portincasa P; Gobbetti M
Curr Med Chem; 2019; 26(19):3567-3583. PubMed ID: 28462705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
